Use of rotigotine to treat depression

The present invention relates to the use of rotigotine [(-) - 5,6,7,8-tetrahydro-6- [propyl [2- (2-thienyl) ethyl] amino] -1-naphthol] and its prodrugs and pharmaceutically aktzeptablen salts for the manufacture of a medicament for the treatment of depression.